Bridging the gap between Technical Reality (OT) and Commercial Strategy. I help Life Science boards and Manufacturing SMEs de-risk capital investment and accelerate digital maturity.
Technical complexity is a primary source of boardroom risk. As an Exceptional NED (Leeds) and Chartered Engineer, I provide the independent oversight needed to ensure multi-million pound digital transformations deliver genuine ROI and regulatory compliance.
Bolstered by a Leeds MBA (Distinction) and the Dean's Prize 2025, I translate complex OT automation challenges into the financial and strategic language of the C-Suite.
My advisory practice is built on a commitment to **Section 172 of the Companies Act 2006** and the **Wates Corporate Governance Principles**. I provide Boards with independent assurance on non-financial risks often missed by generalists:
Providing independent challenge and technical-to-commercial translation. Specialising in Audit and Risk Committees for high-growth SMEs and Life Science firms.
Serving as a "Boardroom Bridge" during major facility expansions or MES/DCS deployments. Ensuring vendor delivery meets stringent GxP and ROI requirements.
Strategic definition for the full ISA-95 stack. I help boards move from operational silos to data-driven, globally compliant manufacturing architectures.
30 years of excellence delivering for global leaders including Novo Nordisk, GE Healthcare, and Takeda.